Home › Funds › Vivo Capital, LLC › ORIC
Vivo Capital, LLC position in ORIC
ORIC PHARMACEUTICALS INC · Health Care
Vivo Capital, LLC reported holding 924,392 shares of ORIC (ORIC PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$12.5M, representing 1.41% of its reported portfolio and ranking #24 among its reported holdings. Vivo Capital, LLC has disclosed ORIC holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Vivo Capital, LLC's ORIC position evolved
Vivo Capital, LLC first disclosed a stake in ORIC in Q3 2023 at 777,944 shares (US$4.7M). The position peaked in Q3 2025 at 3,126,604 shares, worth US$37.5M. Across 13 filings, Vivo Capital, LLC increased the stake 5 time(s), trimmed it 3 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 924,392 shares valued at US$12.5M — a reduction of -924,394 shares quarter over quarter.. Notable position changes include a 63% increase in Q1 2025 (shares rose 82% over the following quarter), a 50% increase in Q2 2025 (shares rose 18% over the following quarter), a 50% trim in Q3 2026 (shares fell 42% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 777.94K | $4.71M | New |
| Q4 2023 | 849.68K | $7.82M | Add |
| Q1 2024 | 849.68K | $11.68M | Hold |
| Q2 2024 | 1.27M | $8.98M | Add |
| Q3 2024 | 1.28M | $13.10M | Add |
| Q4 2024 | 1.28M | $10.31M | Hold |
| Q1 2025 | 2.08M | $11.61M | Add |
| Q2 2025 | 3.13M | $31.74M | Add |
| Q3 2025 | 3.13M | $37.52M | Hold |
| Q4 2025 | 2.12M | $17.33M | Reduce |
| Q1 2026 | 1.85M | $23.42M | Reduce |
| Q2 2026 | 1.85M | $20.02M | Hold |
| Q3 2026 | 924.39K | $12.45M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ORIC and 13F data
ORIC (ORIC PHARMACEUTICALS INC) is a Health Care company. 40 other funds we track also report a position in ORIC — the largest reported positions include Nextech Invest Ltd. (US$77.6M), EcoR1 Capital, LLC (US$72.9M), SR ONE CAPITAL MANAGEMENT, LP (US$50.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ORIC
- Nextech Invest Ltd. 7.16M sh · $77.57M · Q2 2026
- EcoR1 Capital, LLC 6.73M sh · $72.87M · Q2 2026
- SR ONE CAPITAL MANAGEMENT, LP 4.62M sh · $49.98M · Q2 2026
- Venrock Adviser, LLC 4.32M sh · $46.78M · Q2 2026
- Siren, L.L.C. 3.36M sh · $45.23M · Q3 2026
- NEA Management Company, LLC 4.12M sh · $44.60M · Q2 2026
- AIHC Capital Management Ltd 3.83M sh · $41.46M · Q2 2026
- Column Group LLC 3.54M sh · $38.35M · Q2 2026
- First Turn Management, LLC 2.02M sh · $21.85M · Q2 2026
- Integral Health Asset Management, LLC 1.90M sh · $20.58M · Q2 2026
- MPM BioImpact LLC 1.88M sh · $20.38M · Q2 2026
- Defilade Capital Management, L.P. 1.05M sh · $11.35M · Q2 2026
More on Vivo Capital, LLC
FAQ
How long has Vivo Capital, LLC held ORIC?
Vivo Capital, LLC has disclosed ORIC holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Vivo Capital, LLC's current position in ORIC?
As of Q3 2026, Vivo Capital, LLC holds 924.39K shares of ORIC (ORIC PHARMACEUTICALS INC), valued at $12.45M, representing 1.41% of its reported portfolio and ranking #24.
Has Vivo Capital, LLC been buying or selling ORIC?
In the latest 13F filing (Q3 2026), Vivo Capital, LLC reduced its position in ORIC. The position peaked in Q3 2025 at 3.13M shares.
Which other funds hold ORIC?
Other major institutional holders of ORIC include Nextech Invest Ltd., EcoR1 Capital, LLC, SR ONE CAPITAL MANAGEMENT, LP, among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.